Effects of in-hospital diuretic therapy on electrolytes concentration, renal function and survival in 85 dogs with acute congestive heart failure by E. Martinelli et al.
Effects of in-hospital diuretic therapy on electrolytes concentration, renal 
function and survival in 85 dogs with acute congestive heart failure 
E. Martinelli1, A. Galizzi2, R. Toschi Corneliani1, C. Locatelli2 
1San Francesco Veterinary Hospital, Milano, Italy 
2Cardiology Service, Department of Veterinary Medicine, University of Milan, 
Milano, Italy 
 
Critically hill patients with acute congestive heart failure (CHF) may often show haemoconcentration, 
dysnatremia, dyskalemia and increased azotemia, due to aggressive diuretic therapy. Haemocon-centration 
is associated with lower risk of mortality, while dysnatremia and dyskalemia are associated with higher 
mortality in human medicine. The aim of this study was to retrospectively evaluate the impact of in-
hospital diuretic therapy for CHF on selected laboratory parameters and long-term mortality. Dogs with 
clinical and radiological evidence of CHF confirmed by echocardiography were included. Blood samples 
collected through out the hospitalization at presentation (T0) and discharge (T1) were: venous blood gas 
analysis (VBGA), serum creatinine (sCr), blood ureanitrogen (BUN), microhematocrit (Htc) and total proteins 
(TP). Length of hospital stay, ACVIM class and other clinical indices were recorded. Haemoconcentration 
was defined as a simultaneous increase in Htc and total protein. A total of 85 dogs (45 male and 40 female; 
mean age 11.07 ± 2.54 years; mean weight 8.86 ± 6.92 kg) were included. Thirty-six dogshad previous 
episodes of CHF. Mean length of in-hospital stay was 31.15 ± 17.35 hours. Treatment protocol included a 
single furosemide endovenous bolus at 2 mg/kg followed by multiple 1 mg/kg bolus/hour until respiratory 
rate reach 40 respiratory rate. Each dog received 8.6 ± 2.8 mg/kg and 11.1 ± 2.9 mg/kg furosemide in 24 
and 48 hours respectively. Ten dogs received higher furosemide doses or torasemide bolus. 
Haemoconcentration was reached in the 33% of dogs. Considering the VBGA and biochemistry results, the 
number of dogs showing extra-range values (T0-T1) were respectively: hyponatremia (10-23), 
hypernatremia (13-17), hypokalemia (18-30), hyperkalemia (10-10), hypocloremia (46-61), increased BUN 
(26-34), increased sCr (3-8). Fourty-one dogs experienced cardiac death, 12 during hospitalization, the 
remaining dogs between 3 and 721 days after admission. Stepwise backward regression demonstrated 
haemoconcentration (HR 0.33) and disnatremia (HR 2.85) influence over outcome. Statisti-cally significant 
correlation (Pearson) was seen between furosemide dose and kalemia (r = −0.32, P = 0.014) and between 
BUN and sCr (r = 0.27, P = 0.021). No correlation was seen between furosemide dose and the variables sCr, 
BUN, Htc and between sCr and Htc. In conclusion, haemoconcentration and disnatremia affected the out-
come in dogs with CHF. Haemoconcentration was associated withlower risk of mortality and had to be 
considered a target in CHF therapy. In-hospital diuretic therapy increased electrolyte disorder due to loop 
diuretics inhibition of the renal Na, K, Cl cotransporter in the Henle's loop and disnatremia was a risk factor 
for adverse outcome. Diuretics doses and haemoconcentration didn't play a direct role in inducing renal 
disfunction. 
